In vitro assessment of methylene blue on chloroquine-sensitive and -resistant Plasmodium falciparum strains reveals synergistic action with artemisinins

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 11, 2005, Pages 4592-4597

  Akoachere, Monique ^a   Buchholz, Kathrin ^a,b   Fischer, Elisabeth ^a   Burhenne, Jürgen ^b   Haefeli, Walter E ^b   Schirmer, R Heiner ^b   Becker, Katja ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTEMETHER; ARTEMISININ; ARTESUNATE; CHLOROQUINE; ENDOPEROXIDE; MEFLOQUINE; METHYLENE BLUE; PIPERAQUINE; PRIMAQUINE; QUININE; QUINOLINE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CELL CULTURE; DRUG ACTIVITY; DRUG POTENTIATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IC 50; MALARIA; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY;

ANIMALS; ARTEMISININS; CHLOROQUINE; DRUG RESISTANCE; DRUG SYNERGISM; ERYTHROCYTES; METHYLENE BLUE; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; SESQUITERPENES;

EID: 27644471426     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.11.4592-4597.2005     Document Type: Article

References (38)

1. Anstey, N. M., M. Y. Hassanali, J. Mlalasi, D. Manyenga, and E. D. Mwaikambo. 1996. Elevated levels of methaemoglobin in Tanzanian children with severe and uncomplicated malaria. Trans. R. Soc. Trop. Med. Hyg. 90:147-151.
2. Atamna, H., M. Krugliak, G. Shalmiev, E. Deharo, G. Pescarmona, and H. Ginsburg. 1996. Mode of antimalarial effect of methylene blue and some of its analogues on Plasmodium falciparum in culture and their inhibition of P. vinkei petteri and P. yoelii nigeriensis in vivo. Biochem. Pharmacol. 51:693-700.
3. Becker, K., S. Rahlfs, C. Nickel, and R. H. Schirmer. 2003. Glutathione-functions and metabolism in the malarial parasite Plasmodium falciparum. Biol. Chem. 384:551-566.
4. Becker, K., L. Tilley, J. L. Vennerstrom, D. Roberts, S. Rogerson, and H. Ginsburg. 2004. Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions. Int. J. Parasitol. 34:163-189.
5. Clark, W. M., B. Cohen, and H. D. Gibbs. 1925. Studies on oxidation-reduction. VIII. Methylene blue. Public Health Rep. 40:1131-1202.
6. Coulibaly, B., J. Eubel, S. Gromer, and R. H. Schirmer. 2005. Biochemistry based health care research. Methylene blue, malaria, methemoglobin, and malnutrition, p. 285-292. In H. Becher and B. Kouyaté (ed.), Health research in developing countries. Springer-Verlag, Heidelberg, Germany.
7. Davioud-Charvet, E., S. Delarue, C. Biot, B. Schwöbel, C. C. Boehme, A. Müssigbrodt, L. Maes, C. Sergheraert, P. Grellier, R. H. Schirmer, and K. Becker. 2001. A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline. J. Med. Chem. 44:4268-4276.
8. Davis, T. M. E., H. A. Karunajeewa, and K. F. Ilett. 2005. Artemisinin-based combination therapies for uncomplicated malaria. Med. J. Aust. 182:181-185.
9. Desjardins, R. E., C. J. Canfield, J. D. Haynes, and J. D. Chulay. 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chcmother. 16:710-718.
10. Dubois, V. L., D. F. Platel, G. Pauly, and J. Tribouley-Duret. 1995. Plasmodium berghei: implication of intracellular glutathione and its related enzymes in chloroquine resistance in vivo. Exp. Parasitol. 81:117-124.
11. Eckstein-Ludwig, U., R. J. Webb, I. D. A. van Goethem, J. M. East, A. G. Lee, M. Kimura, P. M. O'Neill, P. G. Bray, S. A. Ward, and S. Krishna. 2003. Artemisinins target the SERCA of Plasmodium falciparum. Nature 424:957-961.
12. Färber, P. M., L. D. Arscott, C. H. Williams, K. Becker, and R. H. Schirmer. 1998. Recombinant Plasmodium falciparum glutathione reductase is inhibited by the antimalarial dye methylene blue. FEBS Lett. 422:311-314.
13. Fivelman, Q. L., I. S. Adagu, and D. C. Warhurst. 2004. Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum. Antimicrob. Agents Chemother. 48:4097-4102.
14. Ginsburg, H. (ed.). 2003. Redox metabolism in malaria: from genes, through biochemistry and pathology, to drugs. Redox Rep. 8:231-317.
15. Ginsburg, H., and J. Golenser. 2003. Glutathione is involved in the antimalarial action of chloroquine and its modulation affects drug sensitivity of human and murine species of Plasmodium. Redox Rep. 8:276-279.
16. Goluboff, N., and R. Wheaton. 1961. Methylene blue induced cyanosis and acute haemolytic anemia complicating the treatment of methemoglobinaemia. J. Pediatr. 58:86-89.
17. Haynes, R. K., and S. Krishna. 2004. Artemisinins: activities and actions. Microbes Infect. 6:1339-1346.
18. Krauth-Siegel, R. L., H. Bauer, and R. H. Schirmer. 2005. Dithiol proteins as guardians of the intraccllular redox milieu in parasites: old and new drug targets in trypanosomes and malaria-causing plasmodia. Angew. Chem. Int. Ed. Engl. 44:690-715.
19. Krishna, S. 2005. New ideas about how artemisinins work, p. 2. First Annu. BIOMALPAR Conf. Biol. Pathol. Malaria Parasite. EMBL, Heidelberg, Germany.
20. Lambros, C., and J. P. Vanderberg. 1979. Synchronisation of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65:418-420.
21. Maitland, K., M. Makanga, and T. N. Williams. 2004. Falciparum malaria: current therapeutic challenges. Curr. Opin. Infect. Dis. 17:405-412.
22. Mandi, G., S. Witte, P. Meissner, B. Coulibaly, U. Mansmann, J. Rengelshausen, W. Schick, A. Jahn, M. Sanon, K. Wüst, I. Walter-Sack, G. Mikus, J. Burhenne, K. D. Riedel, R. H. Schirmer, B. Kouyaté, and O. Müller. 2005. Safety of the combination of chloroquine and methylene blue in healthy adult men with G6PD deficiency from rural Burkina Faso. Trop. Med. Int. Health 10:32-38.
23. Meierjohann, S., R. D. Walter, and S. Müller. 2002. Regulation of the intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. Biochem. J. 368:761-768.
24. Meissner, P., G. Mandi, S. Witte, B. Coulibaly, U. Mansmann, J. Rengelshausen, W. Schiek, A. Jahn, M. Sanon, T. Tapsoba, I. Walter-Sack, G. Mikus, J. Burhenne, K. D. Riedel, R. H. Schirmer, B. Kouyaté, and O. Müller. Safety of the combination of chloroquine and methylene blue in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso. Malar. J., in press.
25. Ohrt, C., G. D. Willingmyre, P. Lee, C. Knirsch, and W. Milhous. 2002. Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum in vitro. Antimicrob. Agents Chemother. 46:2518-2524.
26. Peter, C., D. Hongwan, A. Küpfer, and B. H. Lauterburg. 2000. Pharmacokinetics and organ distribution of intravenous and oral methylene blue. Eur. J. Clin. Pharmacol. 56:247-250.
27. Peters, W. 1970. Chemotherapy and drug resistance in malaria. Academic Press, London, United Kingdom.
28. Rengelshausen, J., J. Burhenne, M. Fröhlich, Y. Tayrouz, S. K. Singh, K.-D. Riedel, O. Müller, T. Hoppe-Tichy, W. E. Haefeli, G. Mikus, and I. Walter-Sack. 2004. Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria. Eur. J. Clin. Pharmacol. 60:709-715.
29. Ridley, R. G. 2003. To kill a parasite. Nature 424:887-889.
30. Ridley, R. G., A. Dorn, S. Vippagunta, and J. Vennerstrom. 1997. Haematin (haem) polymerization and its inhibition by quinoline antimalarials. Ann. Trop. Med. Parasitol. 91:559-566.
31. Roll Back Malaria. June 2004, posting date. The RBM Partnership's global response: a programmatic strategy 2004-2008. [Online.] http//rbm.who.int /partnership/board/meetings/docs/strategy_rev.pdf.
32. Schirmer, R. H., B. Coulibaly, A. Stich, M. Scheiwein, H. Merkle, J. Eubel, K. Becker, H. Becher, O. Muller, T. Zieh, W. Schick, and B. Kouyaté. 2003. Methylene blue as an antimalarial agent. Redox Rep. 8:272-276.
33. Su, X., L. A. Kirkman, H. Fujioka, and T. E. Wellems. 1997. Complex polymorphisms in an -330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa. Cell 91:593-603.
34. Trager, W., and J. B. Jensen. 1976. Human malaria parasites in continuous culture. Science 193:673-675.
35. Valecha, N., S. Biswas, A. Srivastava, and U. Devi. 1992. Potentiation of chloroquine action against Plasmodium falciparum in vitro by verapamil and cyproheptadine. Indian J. Pharmacol. 24:158-162.
36. Vennerstrom, J. L., M. T. Makler, C. K. Angerhofer, and J. A. Williams. 1995. Antimalarial dyes revisited: xanthenes, azines, oxazines, and thiazines. Antimicrob. Agents Chemother. 39:2671-2677.
37. Wainwright, M., and L. Amaral. 2005. The phenothiazonium chromophore and the evolution of antimalarial drugs. Trop. Med. Int. Health 10:501-511.
38. Yeung, S., W. Pongtavornpinyo, I. M. Hastings, A. J. Mills, and N. J. White. 2005. Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices. Am. J. Trop. Med. Hyg. 71:179-186.